PSTI

MedAptus Announces Organizational and Management Changes - 11/13 - 07:50 AM ET

PSTI: To Present At Rodman & Renshaw Investment Conference @ 14:25 ET [delayed] - 11/10 - 12:54 PM ET

BRIEF: Pluristem raises $1m in private placement: The company expects to begin clinical trials this year for its product for new blood vessel growth this year. - 09/25 - 04:51 PM ET

Pluristem Therapeutics Inc reports sale of securities - 09/24 - 08:50 AM ET

PSTI: Presents Final Preclinical Efficacy Data re PLX-PAD - 09/16 - 08:19 AM ET

Pluristem Therapeutics concludes preclinical safety studies of ischemia drug - 09/11 - 12:07 PM ET

PSTI: Successful Completion of Preclinical Studies for PLX-PAD - 09/10 - 07:59 AM ET

PSTI: To Present At Noble M.A.D. MAX Equity Conference @ 15:30 ET [delayed] - 08/19 - 01:53 PM ET

PSTI: PLX-MS Demonstrates in Vivo Efficacy for Prevention of Multiple Sclerosis - 08/11 - 08:58 AM ET

PSTI: Haifa, Israel Facility Certified as Good Manufacturing Practices Site - 06/25 - 10:25 AM ET

Pluristem's PLX cells found effective against inflammatory bowel disease - 05/29 - 01:14 PM ET

PSTI: PLX Cells Demonstrate Efficacy for Inflammatory Bowel Disease - 05/28 - 08:27 AM ET

Eclipsys Adds to Board - 05/22 - 02:52 AM ET

PSTI: To Present At Rodman & Renshaw Healthcare Conference @ 03:00 ET [delayed] - 05/20 - 07:27 AM ET

The Street Corner: Market Review on Pluristem Therapeutics, Inc. - 05/15 - 12:15 PM ET

PSTI: Removes Restrictive Legends on Restricted Shares from PIPE - 05/15 - 10:26 AM ET

Pluristem granted approval to conduct arterial disease trials - 05/07 - 10:42 AM ET

PSTI: Paul Ehrlich Institute (Germany) Approves Phase I/II Clinical Trials - 05/06 - 10:22 AM ET

PSTI: To Present At LD Micro Growth Conference @ 20:00 ET [delayed] - 04/29 - 06:23 PM ET

Pluristem shares fall despite MS study: Last week its shares rose 107%. - 04/16 - 05:40 PM ET

Page 1 of 2     1  2      Previous  |  Next

<< Back to Stock Index